Sterling Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9K Sell
921
-20,017
-96% -$469K ﹤0.01% 1825
2026
Q1
$293K Sell
20,938
-12,295
-37% -$166K 0.01% 994
2025
Q4
$373K Buy
33,233
+30,141
+975% +$345K 0.01% 1080
2025
Q3
$35.7K Buy
3,092
+1,875
+154% +$22K ﹤0.01% 1885
2025
Q2
$14.9K Buy
1,217
+434
+55% +$5.46K ﹤0.01% 1909
2025
Q1
$11.2K Sell
783
-672
-46% -$10.5K ﹤0.01% 1828
2024
Q4
$23.2K Buy
1,455
+1,295
+809% +$25.6K ﹤0.01% 1831
2024
Q3
$3.85K Buy
+160
New +$3.66K ﹤0.01% 1860
2017
Q4
Sell
-15,967
Closed -$719K 883
2017
Q3
$719K Sell
15,967
-104
-0.6% -$4.44K 0.01% 717
2017
Q2
$631K Buy
+16,071
New +$607K 0.01% 749

Other funds holding AVNS

Sterling Capital Management's AVNS Position: Q2 2026 in Review

Sterling Capital Management reduced its Avanos Medical (AVNS) stake by 96% in Q2 2026, selling an estimated $469K and leaving 921 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Sterling Capital Management first reported a position in AVNS in Q2 2017 and has held it in 10 quarters since. The position peaked at $719K in Q3 2017. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Sterling Capital Management held 921 shares of Avanos Medical worth $22.9K as of Q2 2026.
  • Sterling Capital Management sold 20,017 Avanos Medical shares in Q2 2026, an estimated $469K.
  • Avanos Medical made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1825 holding.
  • Sterling Capital Management first reported a position in Avanos Medical in Q2 2017 and has held it in 10 quarters since.
  • Sterling Capital Management's Avanos Medical position peaked at $719K in Q3 2017.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.